Grey Matters Health rebrands around a new brain health vision

After 5 years gathering and advancing a pharmaceutical pipeline that proved hard to fund, Christopher Moreau decided it was clip to find a caller currency travel focused way successful healthcare that could supply explosive returns for investors. The effect is Grey Matters Health (CSE:GREY, OTCQB:AGNPD, FRA:AGW0) — a rebranded, refocused institution with a singular mission: to physique the United States' archetypal dedicated encephalon PET scan diagnostic network, starting with a flagship session successful Florida acceptable to unfastened successful September.

"When caller investors travel to the story, they volition observe a new, breathtaking and compelling communicative says Moreau, the company's CEO. "This is truly a caller commencement and a caller direction."

The rebrand from Algernon Health reflects some a alteration successful individuality and a alteration successful strategy. Drug repurposing, the company's archetypal focus, is capital-intensive by nature, and entree to that superior proved elusive for a CSE-listed steadfast locked retired of US organization funds due to the fact that they are incapable to bargain oregon put successful CSE listed stocks. Nuclear medicine and neuroimaging, Moreau concluded, offered a much accessible way to gathering a sustainable, cash-generating healthcare business. Whether he's close remains to beryllium seen — but the archetypal session volition connection an aboriginal test.

Why encephalon diagnostics, and wherefore present

The determination into neuroimaging wasn't arbitrary. Several converging developments made the assemblage look compelling. First, the FDA approved 2 antibody therapies for Alzheimer's illness targeting amyloid plaque buildup successful the brain, but accessing either attraction requires diagnostic confirmation done a encephalon PET scan oregon spinal tap. That request has created a surge successful request among the astir 7 cardinal Americans presently surviving with Alzheimer's. Second, Medicare and Medicaid removed a erstwhile once-in-a-lifetime bounds connected encephalon PET scans. Third, the FDA approved a caller brain-only PET scanner that Grey Matters tin entree done a concern with Catalyst Med Tech.

Meanwhile, neurological imaging has agelong been deprioritized by hospitals and accepted imaging centers. Standard PET-CT systems are chiefly configured for abdominal crab and cardiac diagnostic and theranostic imaging — lone astir 10% of scans contiguous are neurological. Neuro scans instrumentality longer, generating little gross for facilities with competing priorities. The result, Moreau argues, is simply a increasing spread betwixt request and disposable capacity.

A PET scanner that changes the diligent acquisition

At the halfway of Grey Matters' exemplary is exertion that looks considerably antithetic from a accepted PET/CT machine. Traditional systems measurement up to 11,000 pounds, outgo betwixt $3 cardinal and $5 cardinal and necessitate hundreds of thousands much successful installation and pb partition and doorway protection. They besides necessitate patients to prevarication level connected a constrictive array and determination into a ample halo structure, which tin beryllium distressing for a steadfast person, ne'er caput patients managing representation nonaccomplishment oregon cognitive decline. Many neuro-degenerative illness patients are older and the question of the scanner array into the scanner tin besides origin dizziness and claustrophobic events.